PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
HIV Seropositivity D006679 15 associated lipids
Fetal Alcohol Spectrum Disorders D063647 6 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Chondrosarcoma D002813 9 associated lipids
Dirofilariasis D004184 3 associated lipids
Hyperlipoproteinemias D006951 15 associated lipids
Hypothermia D007035 19 associated lipids
Retinopathy of Prematurity D012178 9 associated lipids
Parkinson Disease D010300 53 associated lipids
Down Syndrome D004314 18 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Barrow SE et al. Measurement of prostaglandin D2 and identification of metabolites in human plasma during intravenous infusion. 1984 Prostaglandins pmid:6441188
Bertelé V et al. Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: modulatory role of cyclooxygenase products. 1984 Blood pmid:6426554
Gresele P et al. Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2. 1984 Biochem. Pharmacol. pmid:6430299
Vicenzi E et al. Human mononuclear phagocytes from different anatomical sites differ in their capacity to metabolize arachidonic acid. 1984 Clin. Exp. Immunol. pmid:6432383
Nishi S et al. Different effects of prostaglandin E1, E2 and D2 on pancreatic somatostatin release. 1984 Horm. Metab. Res. pmid:6152434
Neely SM et al. Mechanism and characteristics of platelet activation by haematin. 1984 Br. J. Haematol. pmid:6383458
Dembinska-Kieć A et al. Formation of leukotriene C4-like material by rat brain tissue. 1984 Eur. J. Pharmacol. pmid:6426980
Kawamura M and Koshihara Y Prostaglandin D2 lowers nuclear DNA polymerase activity in cultured mastocytoma cells. 1984 Prostaglandins pmid:6427850
Vincent JE et al. The effect of 5-(2-chlorobenzyl)-5,6,7,7a-tetrahydro 4H-thieno (3.2-C)-pyridine-2-one hydrochloride (PCR 3787), a metabolite of ticlopidine, on the aggregation of human platelets in vitro and on the aggregation inhibiting action of PGI2 and PGD2. 1984 Prostaglandins Leukot Med pmid:6396655
Weichman BM et al. SK&F 88046: a unique pharmacologic antagonist of bronchoconstriction induced by leukotriene D4, thromboxane and prostaglandins F2 alpha and D2 in vitro. 1984 J. Pharmacol. Exp. Ther. pmid:6582266
Higashida H et al. Facilitation of synaptic transmission by prostaglandin D2 at synapses between NG108-15 hybrid and muscle cells. 1984 Brain Res. pmid:6324947
Bertelé V et al. SQ 22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitor. 1984 Thromb. Haemost. pmid:6326343
Chapnick BM Divergent influences of leukotrienes C4, D4, and E4 on mesenteric and renal blood flow. 1984 Am. J. Physiol. pmid:6326595
Gardiner PJ and Browne JL Tussive activity of inhaled PGD2 in the cat and characterisation of the receptor(s) involved. 1984 Prostaglandins Leukot Med pmid:6328541
Zavoico GB and Feinstein MB Cytoplasmic Ca2+ in platelets is controlled by cyclic AMP: antagonism between stimulators and inhibitors of adenylate cyclase. 1984 Biochem. Biophys. Res. Commun. pmid:6329175
Pan IQ et al. Alteration of platelet responses to metabolites of arachidonic acid by oral contraceptives. 1984 Br. J. Haematol. pmid:6089860
Nilsson J and Olsson AG Prostaglandin E1 inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. 1984 Atherosclerosis pmid:6093830
Seregi A et al. Decreased levels of brain cyclo-oxygenase products as a possible cause of increased seizure susceptibility in convulsion-prone gerbils. 1984 Brain Res. pmid:6430471
Ikai K et al. Prostaglandin D2 and prostaglandin D synthetase in mast cell deficient mice. 1984 Prostaglandins pmid:6435183
Uemura S et al. Inotropic effects of prostaglandin D2 and E1 on the newborn rabbit heart. 1984 Pediatr. Res. pmid:6596550
Heavey DJ et al. Effects of intravenous infusions of prostaglandin D2 in man. 1984 Prostaglandins pmid:6596653
Mahmud I et al. On the identification and biological properties of prostaglandin J2. 1984 Prostaglandins Leukot Med pmid:6597446
Arisawa M et al. Direct suppressive effect of prostaglandin D2 on growth hormone secretion from rat anterior pituitary. 1984 Asia Oceania J Obstet Gynaecol pmid:6598030
Newman JH and Sheller JR Arachidonic acid metabolites in the healthy and diseased lung. 1984 Am. J. Med. Sci. pmid:6091454
Ogorochi T et al. Regional distribution of prostaglandins D2, E2, and F2 alpha and related enzymes in postmortem human brain. 1984 J. Neurochem. pmid:6427411
Imashuku S et al. [Differentiation induction and potentiation of chemotherapy by PGE1 infusion in patients with neuroblastoma--effect of PGE1 on metastatic potential of neuroblastoma]. 1984 Gan To Kagaku Ryoho pmid:6585182
Nakajima M and Toda N Neuroeffector actions of prostaglandin D2 on isolated dog mesenteric arteries. 1984 Prostaglandins pmid:6587438
Andersen NH and Hartzell CJ High-field 1H NMR studies of prostaglandin H2 and its decomposition pathways. 1984 Biochem. Biophys. Res. Commun. pmid:6587849
Gal D et al. Effect of radiation on prostaglandin production by human bowel in vitro. 1984 Int. J. Radiat. Oncol. Biol. Phys. pmid:6588048
Brus R et al. Effect of prostaglandins on morphine-induced catalepsy in mice. 1983 Sep-Dec Acta Physiol Pol pmid:6679984
Gaetani P et al. [Prostaglandin D2 in subarachnoid hemorrhage. Biological and diagnostic implications]. 1983 Jul-Aug Riv Patol Nerv Ment pmid:6598516
Ogino N et al. Phagocytic activity of cultured retinal pigment epithelial cells from chick embryo: inhibition by melatonin and cyclic AMP, and its reversal by taurine and cyclic GMP. 1983 Ophthalmic Res. pmid:6136017
Ruzicka T et al. Inhibition of rat mast cell arachidonic acid cyclooxygenase by dapsone. 1983 J. Allergy Clin. Immunol. pmid:6413566
Whittle BJ et al. Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue. 1983 Prostaglandins pmid:6344147
Naclerio RM et al. Mediator release after nasal airway challenge with allergen. 1983 Am. Rev. Respir. Dis. pmid:6354022
Inoué S [Sleep substances: their roles and evolution]. 1983 Seikagaku pmid:6355327
Tasaka K et al. Prostaglandin D2 induces release of luteinizing hormone from the rat pituitary gland without the modulation of hypothalamic luteinizing hormone releasing hormone. 1983 J. Endocrinol. pmid:6361197
Schleimer RP et al. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. 1983 J. Clin. Invest. pmid:6134755
Gimeno AL et al. Prostacyclin induces a surprising long-lasting motility in quiescent uterine strips (indomethacin-treated) isolated from ovariectomized rats. 1983 Prostaglandins pmid:6361911
Scott HW et al. Hazards in operative management of patients with systemic mastocytosis. 1983 Ann. Surg. pmid:6189461
Stringfellow DA Prostaglandins and metastasis. 1983 Symp Fundam Cancer Res pmid:6206537
Feinstein MB et al. The cytoplasmic concentration of free calcium in platelets is controlled by stimulators of cyclic AMP production (PGD2, PGE1, forskolin). 1983 Biochem. Biophys. Res. Commun. pmid:6307295
Ruzicka T et al. Changes in arachidonic acid metabolism in UV-irradiated hairless mouse skin. 1983 J. Invest. Dermatol. pmid:6578273
Soifer SJ et al. The developmental effects of prostaglandin D2 on the pulmonary and systemic circulations in the newborn lamb. 1983 J. Dev. Physiol. pmid:6579103
Miyake A et al. Prostaglandin D2 stimulates secretion of luteinizing hormone from pituitary gland in vitro. 1983 Acta Endocrinol. pmid:6579807
Belegu M et al. beta-Adrenergic blockade of prostaglandin E2- and D2-induced erythroid colony formation. 1983 Am. J. Physiol. pmid:6579847
Lysz TW et al. Measurement of prostaglandin biosynthetic capacity in discrete areas of the rabbit hippocampal formation. 1983 J. Neurosci. Res. pmid:6580469
Ishizawa M Contractile effects of PGD2 and PGF2 alpha on mechanical and electrical activities in longitudinal and circular muscles of the guinea-pig colon. 1983 Prostaglandins pmid:6580679
Bregman MD and Meyskens FL In vitro modulation of human and murine melanoma growth by prostanoid analogues. 1983 Prostaglandins pmid:6581509
Carr BR et al. Prostaglandin secretion by the neocortex and fetal zones of the human fetal adrenal gland. 1983 J. Clin. Endocrinol. Metab. pmid:6313732